Danish pharma major Novo Nordisk (NOV: N) late Thursday announced that the US Food and Drug Administration (FDA) has approved Wegovy HD (once-weekly injectable semaglutide 7.2mg) to reduce excess body weight and maintain weight reduction long-term
We are proud to offer pure, potent, and quality products that consumers can count on, which is why we have every product batch third-party tested
Although several type 2 diabetes treatments are available, therapy selection involves consideration of the risks of adverse effects such as hypoglycemia (low blood sugar) or weight gain and complexity of treatment
If further weight loss is needed and the medication is well-tolerated, the dose can be increased in 2.5 mg increments (to 7.5 mg, 10 mg, 12.5 mg, and up to the maximum of 15 mg once weekly for Zepbound) generally every 4 weeks
Yes- RDs and Pharmacists are essential in managing these side effects, given GI side effects are the primary reason people discontinue in year one